Synaptogenix, Inc.股价上涨10.64% 市值跌6.78万美元

市场透视2025-05-29

北京时间2025年05月29日21时48分，Synaptogenix, Inc.（SNPX.us）股票出现波动，股价快速上涨10.64%。截至发稿，该股报2.39美元/股，成交量251股，换手率0.02%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润385169.00美元，每股收益0.12美元，毛利-1032.00美元，市盈率-0.20倍。机构评级方面，目前暂无机构对该...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2539650102?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-29 21:48","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2539650102","market":"us","top_or_hot":-1,"title":"Synaptogenix, Inc.股价上涨10.64% 市值跌6.78万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月29日21时48分，Synaptogenix, Inc.（SNPX.us）股票出现波动，股价快速上涨10.64%。截至发稿，该股报2.39美元/股，成交量251股，换手率0.02%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润385169.00美元，每股收益0.12美元，毛利-1032.00美元，市盈率-0.20倍。机构评级方面，目前暂无机构对该...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529214819a491706a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Synaptogenix, Inc.股价上涨10.64% 市值跌6.78万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSynaptogenix, Inc.股价上涨10.64% 市值跌6.78万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-29 21:48 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529214819a491706a&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月29日21时48分，Synaptogenix, Inc.（SNPX.us）股票出现波动，股价快速上涨10.64%。截至发稿，该股报2.39美元/股，成交量251股，换手率0.02%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润385169.00美元，每股收益0.12美元，毛利-1032.00美元，市盈率-0.20倍。机构评级方面，目前暂无机构对该...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529214819a491706a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALZN","symbol_name":"Alzamend Neuro, Inc","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529214819a491706a&s=b","article_id":"2539650102","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529214819a491706a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2539650102","pubTimestamp":1748526498,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月29日21时48分，Synaptogenix, Inc.股票出现波动，股价快速上涨10.64%。截至发稿，该股报2.39美元/股，成交量251股，换手率0.02%，振幅0.00%。Synaptogenix, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Synaptogenix, Inc.公司简介：Synaptogenix Inc 是一家生物制药公司，在临床前和临床开发中具有产品候选者。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ALZN":"Alzamend Neuro, Inc","BK4539":"次新股","SNPX":"2倍做多SNPS ETF-Tradr","BK4139":"生物科技"},"translate_title":"Synaptogenix, Inc. Shares Rise 10.64%, Market Cap Down $67,800","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNPX":0.9,"ALZN":0.86},"content_text":"北京时间2025年05月29日21时48分，Synaptogenix, Inc.（SNPX.us）股票出现波动，股价快速上涨10.64%。截至发稿，该股报2.39美元/股，成交量251股，换手率0.02%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润385169.00美元，每股收益0.12美元，毛利-1032.00美元，市盈率-0.20倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Synaptogenix, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Alzamend Neuro, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)、Oric Pharmaceuticals, Inc.涨幅较大，Alzamend Neuro, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为5767.60%、483.24%、271.47%，振幅较大的相关个股有Alzamend Neuro, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 (To Pur Com)、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 (To Pur Com)，振幅分别为40.96%、40.90%、26.28%。Synaptogenix, Inc.公司简介：Synaptogenix Inc 是一家生物制药公司，在临床前和临床开发中具有产品候选者。它主要侧重于开发一个基于一种名为布约他汀的药物候选药物的产品平台，用于治疗阿尔茨海默氏症，目前正处于临床测试阶段。它还在评估布赖他汀的其他神经退行性或认知性疾病和功能障碍，如脆弱X综合征，多发性硬化症和尼曼-皮克C型疾病，这些疾病已经经过临床前测试。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2539650102","isCrawlerRequest":true}